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1.16, 3.94), and age (OR 1.03 per year, 95% CI 1.01, 1.06) were
significantly associated with an increased mortality risk, whereas blood
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Abstract: Only a few studies provided data on the clinical history of
sepsis within internal Medicine units.
The aim of the study was to assess the short-term mortality and to
evaluate the prognostic risk factors in a large cohort of septic patients
treated in internal medicine units.
Thirty-one internal medicine units participated to the study. Within
each participating unit, all admitted patients were screened for the
presence of sepsis.
A total of 533 patients were included; 78 patients (14.6%, 95%CI
11.9, 18.0%) died during hospitalization; mortality rate was 5.5% (95%
CI 3.1, 9.6%) in patients with nonsevere sepsis and 20.1% (95%CI 16.2,
28.8%) in patients with severe sepsis or septic shock. Severe sepsis or
septic shock (OR 4.41, 95%CI 1.93, 10.05), immune system weakeningragiola, MEng, Gi MD,
izio Colombo, MD, and Mauro Campanini, MD
culture positive for Escherichia coli was significantly associated with a
reduced mortality risk (OR 0.46, 95%CI 0.24, 0.88).
In-hospital mortality of septic patients treated in internal medicine
units appeared similar to the mortality rate obtained in recent studies
conducted in the ICU setting.
(Medicine 95(4):e2124)
Abbreviations: CI = confidence interval, CREMS = center for
research on health economics social and health care management,
FADOI = federation of associations of executives of hospital
internists, ICU = intensive care unit, ORs = odds ratios, SD =
standard deviation.
INTRODUCTION
S epsis is a frequent inflammatory disease with a highmortality and morbidity rate.1 Over the past few years, a
number of different studies have reported an increasing inci-
dence of this disease.2–4
Information on the epidemiology, causes, andmanagement
and prognosis of patients with sepsis came mainly from studies
conducted within intensive care units (ICUs).2,5,6 However, a
consistent number of studies suggest that a significant pro-
portion of patients with sepsis (including those with severe
sepsis) are admitted to internal medicine units, and not trans-
ferred to an ICU.7,8 Unfortunately only a few provided data on
the epidemiology and management of sepsis in the internal
medicine setting.8 Some studies have reported a higher
mortality rate in patients with sepsis not admitted or with a
delayed admission to an ICU.9,10 However, these studies were
published before the implementation of recent international
guidelines on the management of severe sepsis and septic
shock.6 Thus, information on the clinical history of patients
with sepsis treated outside an ICU is extremely limited.
Therefore, to address this knowledge gap, we conducted a
perspective multicenter study, evaluating consecutive patients,
with an objective diagnosis of sepsis treated in internal medi-
cine units.
METHODS
A protocol detailing specific objectives of the study and
patients’ inclusion and exclusion criteria was developed by the
Federation of Associations of Executives of Hospital Internists
(FADOI) in collaboration with the Institute of Health and theand the Centre for Research on Health
Health Care Management (CREMS), of
neo—LIUC.
www.md-journal.com | 1
At each of the participating centers, the ethics committee
approved the study protocol and waived the need for
informed consent.
Patients
Thirty-one internal medicine units from 14 different Italian
regions participated in the study (the complete list of participat-
ing centers is shown in Appendix 1). Consecutive patients with
an objective diagnosis of sepsis, admitted to these units from
March 1, 2012, to December 31, 2012, were included. A
minimum of 15 patients was requested to each participating
center and only adult patients with positive blood cultures were
included. Patients transferred to the ICU from the emergency
room were not included.
In each participating unit, all patients were actively
screened for the presence of sepsis defined as a systemic
inflammatory response secondary to infection (see ‘‘Defi-
nitions’’ below for detailed information). All the admitted
patients who developed sepsis were initially enrolled. Patients
in which blood cultures resulted negative were subsequently
excluded from the study. Patients were followed up to discharge
from the hospital to detect the presence of sepsis. Investigators
in charge for the enrolment were physicians trained for the
identification of patients with sepsis criteria. Although the use
of most recent (at the time of the enrolment) available guide-
lines on this topic11 has been recommended, due to the observa-
tional nature of our study, decisions on the management and
treatment of septic patients were left to the local investigators.
At the time of enrolment, the following data for each
patient were collected: demographic characteristics (age, gen-
der), reason for admission to the hospital, clinical presen-
tation—including hemodynamic data (heart rate, blood
pressure, temperature), presence of comorbidities, origin of
primary infection (respiratory, gastrointestinal, genitourinary,
or skin-muscle and primary bacteriemia), date of diagnosis of
infection, and cultures performed, along with their results.
Furthermore, information on arterial blood gases was gathered
when available. Subsequently, patients were daily monitored
until the end of hospitalization. Data on patients’ management
(mechanical ventilation, vasoactive drugs, administration of
drotrecogin alpha, dialysis) were recorded. Rate of transfer
to the ICU, length of hospital stay, and in-hospital mortality
were registered for all the patients. For each death, causes of
death were collected.
Case report forms were prepared by the coordinating
center (CREMS) and were sent to all participating subinvesti-
gators. Local investigators were asked to fill out the form and
then return it to the coordinating center. Detailed instructions
explaining the aim of the study, instructions for data collection,
and definitions for various items were available for all inves-
tigators before starting data collection. All data were cross-
checked and centrally validated during the study. Errors or blank
fields generated queries that were returned to each participating
center for correction.
Definitions
Infection was defined as the presence of a pathogenic
micro-organism in a sterile milieu and/or clinically suspected
infection, plus the administration of antibiotics.
As Staphylococcus epidermidis and Staphylococcus homi-
nis may be skin contaminants, patients were considered as
Mazzone et alhaving this infection in the blood only when these 2 bacteria
were isolated from 2 or more blood cultures drawn on separate
occasions as commonly accepted.
2 | www.md-journal.comAccording to the American College of Chest Physicians/
Society of Critical Care Medicine Consensus Conference defi-
nitions, sepsis was defined as infection, plus 2 systemic inflam-
matory response syndrome criteria.12
Severe sepsis was defined as sepsis plus at least 1 organ
dysfunction, except when that organ dysfunction already was
present 48 h before the onset of sepsis.13 Septic shock was
defined as sepsis plus either hypotension refractory to intrave-
nous fluids (defined as persistent hypotension or a requirement
for vasopressors after the administration of an intravenous fluid
bolus) or hyperlactatemia.13 Organ dysfunction was defined in
accordance with commonly established criteria.1
Statistical Analysis
Continuous variables were expressed as mean, plus or
minus the standard deviation (SD), or as median with minimum
and maximum values when data did not have a normal distri-
bution; categorical data are given as counts and percentages.
Percentage of admission for sepsis on the total number of
admissions during the study period was calculated.
The mortality rate of the whole population during hospi-
talization and of patients with severe sepsis and with septic
shock was expressed as percentage (with the corresponding
95% confidence intervals [CI] with continuity correction).
Characteristics of patients who died during hospitalization
and who were discharged alive were compared. We used
Student’s t test or the Mann–Whitney test to compare continu-
ous variables and the chi-square test or Fisher’s exact test to
compare proportions, as appropriate.
Subsequently, all the variables, statistically significant or
marginally significant associated with an increased mortality
risk during hospitalization at the univariate analysis, were
introduced as covariates in a multivariate model (backward
binary logistic regression model) with mortality as the depen-
dent variable. To avoid false negative results, variables were
introduced to the model when P< 0.20 at univariate analysis
and removed from the model in the case of lack of significance.
Results of multivariate analysis were presented as odds ratios
(ORs) and corresponding 95% confidence intervals (CI). Two-
tailed P values< 0.05 were used to indicate statistical signifi-
cance for all the analyses. All the analyses were conducted using
SPSS version 19.0 (SPSS Inc, Chicago, IL).
RESULTS
Baseline characteristics, clinical presentation, and princi-
pal comorbidities were summarized in Table 1. Main isolates at
blood cultures were summarized in Table 2. Five hundred and
thirty-three septic patients (mean age 73.3 years, 50.8% men)
were included representing the 1.78% (95%CI 1.63, 1.95) of the
admissions to the internal medicine units in the same period;
316 patients (59.3%) had a severe sepsis, and 17 (3.2.%) septic
shock at the presentation. Sepsis most frequently came from
genitourinary (30.8%), respiratory tract (26.5%), and gastroin-
testinal tract (18.9%), and 62 patients (11.6%) had a primary
bacteriemia. Almost all the patients (94.2%) had at least 1
comorbidity: cardio or cerebrovascular disease (63.4%) and
diabetes (30.8%) were the most frequent comorbidities. Anti-
biotic therapy was started within 1 h after clinical suspicion of
sepsis in 337 patients (75.9%). There were 626 blood cultures
positive: 313 (50.0%) for Gram-positive bacteria, 293 (46.8%)
Medicine  Volume 95, Number 4, January 2016for Gram-negative bacteria, and only 20 (3.2%) for fungi.
Escherichia coli (29.4%) was the most frequent isolated fol-
lowed by Staphylococcus aureus (12.0%), S. epidermidis
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Baseline Characteristics
Characteristics 533 Patients
Mean age, y (SD) 73.3 (14.6)
Female sex, n (%) 262 (50.8)
Caucasian ethnicity, n (%) 527 (98.8)
Median length of stay, days (range) 15 (1–165)
Severe sepsis, n (%) 316 (59.3)
Septic shock, n (%) 17 (3.2)
Site of the primary infection, n (%)
Genitourinary 164 (30.8)
Respiratory 141 (26.5)
Gastrointestinal 101 (18.9)
Primary bacteremia 62 (12.2)
Skin muscle 49 (9.1)
Other 26 (4.9)
Recent hospitalization (< 3 months), n (%) 189/486 (38.9)
Recent antibiotics use (< 3 months), n (%) 219 (41.1)
Admission from ED, n (%) 462 (86.1)
> 1 comorbidity 502 (94.2)
Mean number of comorbidities, n 2.38 (1.32)
Comorbidity
Cardio-cerebrovascular disease, n (%) 339 (63.4)
Diabetes, n (%) 165 (30.8)
CKD, n (%) 124 (23.2)
Respiratory disease, n (%) 134 (25.1)
Active cancer, n (%) 126 (23.6)
Hepatic disease, n (%) 85 (15.9)
Immune system weakening, n (%) 93 (17.4)
Medicine  Volume 95, Number 4, January 2016 Management of Sepsis in Internal Medicine(12.0%), Enterococcus faecalis (7.4%), and Klebsiella pneu-
moniae (5.4%). In 497 cultures (79.4%) there was at least 1
antibiotic resistance and antibiotic resistance affected 44.7% of
the empiric treatments. In particular, there were 88 ESBL
producers and 22 MRSA. Seventy-eight patients (14.6%,
95% CI 11.9, 18.0%) died during hospitalization and 7 patients
(1.3%) were transferred to the ICU; according to the clinical
presentation mortality was 5.5% (95% CI 3.1, 9.6%) in patients
with nonsevere sepsis, and 20.1% (95% CI 16.2, 28.8%) in
CKD¼Chronic Kidney Disease, ED¼Emergency Department,
SD¼ standard deviation.patients with severe sepsis or septic shock (20.6%, 95%CI 16.5,
25.4% in patients with severe sepsis and 11.8%, 95% CI 3.3,
34.3% in patients with septic shock) (Figure 1).
TABLE 2. Main Isolates at Blood Cultures
Isolate or Micro-organism N (%)
Escherichia coli 184 (29.4)
Staphylococcus aureus 75 (12.0)
Staphylococcus epidermidis 75 (12.0)
Enterococcus faecalis 46 (7,3)
Klebsiella pneumoniae 36 (5,8)
Staphylococcus hominis 29 (4.6)
Enterobacter cloacae 13 (2.1)
Proteus mirabilis 10 (1.6)
Streptococcus pneumoniae 10 (1.6)
Pseudomonas aeruginosa 9 (1.4)
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gender, older age, clinical presentation as severe sepsis or septic
shock, presence of > 1 comorbidity, including active cancer,
personal history of cardio or cerebrovascular disease, personal
history of respiratory disease, and a state of immune system
weakening, were significantly or marginally significantly
associated with an increased mortality risk during hospitaliz-
ation (P< 0.20 for all these variables). All the other variables
evaluated were not significantly associated with an increased
mortality risk (P> 0.20). Furthermore, when we consider the
source of the primary infection, only origin from respiratory
tract was marginally associated with an increased mortality risk
(26/141, 18.4% vs 52/392 for other origins, 13.2%; P¼ 0.16)
whereas all the other origins were not (data available upon
request). Among the different bacteria isolated, blood culture
positive for E. faecalis was significantly associated with an
increased risk of death, whereas E coli infection was associated
with a lower risk of death. Recent hospitalization was also
associated with increased mortality risk at the univariate
analysis, but information on this variable was available only
from 486 patients (91.2% of the whole population).
Using the backward binary logistic regression model,
clinical presentation as severe sepsis or septic shock (OR
4.41 95% CI 1.93, 10.05), immune system weakening (OR
2.10, 95% CI 1.12, 3.94), presence of active solid cancer (OR
2.14, 95% CI 1.16, 3.94), and age (OR 1.03 per year, 95% CI
1.01, 1.06) were significantly associated with an increased
mortality risk during hospitalization, whereas blood culture
positive for E. coli was significantly associated with a reduced
mortality risk (OR 0.46, 95% CI 0.24, 0.88) (Figure 2).
When the multivariate model was repeated, excluding
recent hospitalization from the analysis, the results did not
change (data not shown).
DISCUSSION
Sepsis is an extremely frequent disease and its incidence
continues to increase. The number of cases of severe sepsis in
the United States only exceeds 750,000 per year,1,14 and it ranks
tenth among the most frequent causes of death.4 In our study, we
collected information on a quite large number of patients with
sepsis and with positive blood culture who were consecutively
admitted to an internal medicine unit. The in-hospital mortality
of this population appeared to be in line with the results of recent
studies that have evaluated the prognosis of patients with
FIGURE 1. In-hospital mortality rate according to presentation of
sepsis.sepsis14,15 and that show a declining trend in the hospital
mortality rate of these patients over the past few years.16
Our results may be of clinical relevance for clinicians as, to
www.md-journal.com | 3
TABLE 3. Results Univariate Analysis Comparing Characteristics of Patients Discharged Alive and Died During Hospitalization
Characteristic
Discharged Alive,
455 Patients
Died During Hospital Stay,
78 Patients P
Female sex, n (%) 215 (47.2) 47 (60.2) 0.034
Antibiotic resistance, n (%) 205 (45.0) 32 (41.0) 0.508
Hospital admission in the last 3 months, n (%) 151 (33.2) 38 (48.7) 0.008
Antibiotic treatment in the last 3 months, n (%) 189 (41.5) 30 (38.5) 0.610
Sepsis, n (%) 189 (41.5) 11 (14.1) 0.000
Severe sepsis or MOF, n (%) 251 (55.2) 65 (83.3) <0.001
Septic shock, n (%) 15 (3.3) 2 (2.6) 0.734
Severe sepsis, septic shock, MOF, n (%) 266 (58.5) 67 (85.8) <0.001
Time from sepsis suspicion to empiric therapy < 1 h, n (%) 170 (37.4) 26 (33.3) 0.413
Immunosuppressive or steroid therapy, n (%) 49 (10.8) 19 (24.3) 0.001
Cardiovascular diseases, n (%) 281 61.7) 58 (74.3) 0.033
Lung diseases, n (%) 109 (24.0) 25 (32.0) 0.128
Liver diseases, n (%) 71 (15.6) 14 (17.9) 0.601
Kidney diseases, n (%) 103 (22.6) 21 (26.9) 0.408
Diabetes, n (%) 142 (31.2) 23 (29.5) 0.761
Solid malignancies, n (%) 91 (20.0) 25 (32.0) 0.017
Presence of comorbidities, n (%) 425 (93.4) 77 (98.7) 0.064
Immunodepression without diabetes, n (%) 66 (14.5) 27 (34.6) <0.001
Klebsiella pneumoniae, n (%) 26 (5.7) 7 (8.9) 0.270
Enterococcus faecalis, n (%) 34 (7.5) 10 (12.8) 0.113
Staphylococcus aureus, n (%) 62 (13.6) 8 (10.2) 0.416
Staphylococcus epidermidis, n (%) 51 (11.2) 8 (10.2) 0.804
Escherichia coli, n (%) 156 (34.3) 18 (23.0) 0.051
Mazzone et al Medicine  Volume 95, Number 4, January 2016date, only a few studies have provided information on the
epidemiology and clinical history of patients with sepsis diag-
nosed and treated outside an ICU.8 In fact, a significant
proportion of patients with sepsis and even with severe sepsis
are admitted to an internal medicine unit and not transferred to
an ICU.7 Results of recent studies clearly show that the use of
central venous catheterization to monitor central venous pres-
sure and central venous oxygen saturation to guide the admin-
istration of intravenous fluids, vasopressors, packed red-cell
transfusions, and dobutamine, did not modify the mortality and
n¼ number, MOF¼multiorgan failure.morbidity rate of patients with severe sepsis or septic shock.17,18
Thus, these results seem to suggest that patients may be treated
safely, without the need of a continuous invasive monitoring, in
FIGURE 2. Independent predictors of in-hospital mortality at
multivariate analysis. CI¼ confidence interval, ORs¼odds ratios.
4 | www.md-journal.coma less intensive unit provided that an adequate therapy was
rapidly administered.19 Interestingly, other recent studies con-
ducted on patients with sepsis admitted to ICU showed similar
results, confirming the validity of our findings.20 However,
information on clinical and easily assessable factors, potentially
associated with clinical deterioration and short-term mortality,
remains critical as a delayed transfer to an ICU of these patients
seems to be associated with a worse short-term prognosis.20
Besides the clinical presentation as severe sepsis or septic
shock other factors such as the presence of active solid cancer or
of immune system weakening and age appeared associated with
an increased mortality risk during hospitalization. As no
previous study has specifically assessed the role of potential
risk factors for short-term mortality in patients with sepsis
admitted to an internal medicine unit, it was not possible to
compare our results with preceding literature in this field.
Information on the most frequent infection in different
settings is crucial in order to establish the most appropriate
treatment of patients with sepsis. Gram-positive bacteria were
slightly more prevalent than Gram-negative bacteria (50.0% vs
46.8%) and only 3.2% of blood cultures were positive for fungi.
Escherichia coli was the most frequent bacterium isolated
followed by S. aureus, S. epidermidis and E. faecalis (7.4%).
In previous studies, Gram-positive infections appeared more
frequent than Gram-negative.4 However, more recently, in a
study involving 14,000 ICU patients in 75 countries, Gram-
negative bacteria were isolated in 62% of patients with severe
sepsis with positive cultures, Gram-positive bacteria in 47%,
and fungi in 19%.5
At least 1 antibiotic resistance was present in almost the
80% of the isolated at the blood culture and antibiotic resistance
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
affected almost half of the empiric treatments. Interesting, E.
coli infection was significantly associated with a reduced
mortality risk in comparison to other bacteria at univariate
analysis. Escherichia coli is very common in urinary tract
infection sepsis that has a better prognosis in comparison to
pneumonia-mediated sepsis.5 However, this association
remained significant also at multivariate analysis that took in
consideration among the other variables also the origin of
infection. Finally, different from the results of a recent study
on 327 adult septic patients admitted to ICU, primary bacter-
emia was not associated with an increased mortality risk in our
population.21 Differences in the selection of the population may
explain these different results. Alternatively, as only a small
number of patients had a primary bacteremia in the 2 popu-
lations, these different results may be due to chance.
Our study has strengths and limitations. First, only
patients with positive blood cultures were included in our
study. Although this may be considered to be a selection
and thus the patients may be not representative of general
patients with sepsis admitted to an internal medicine unit, with
this approach we were able to exclude all the patients without a
clear diagnosis of sepsis, increasing the validity of our results.
Second, information on recent hospitalization was not avail-
able in almost 9%of included patients. Although the lack of this
information in a not negligible proportion of patients may
affect the validity of our results, however the repetition of
the multivariate analysis after the exclusion of this parameter
gave similar results minimizing this possibility. In addition,
<1% of data of all the other were missing. Third, results on the
mortality rate of the subgroup of patients with septic shock
should be interpreted with extreme caution as an extremely low
number of patients with this condition (n¼ 17) have been
included in our study. Finally, there may be important differ-
ences in the epidemiology, management and clinical history of
sepsis among the involved centers. However, due to the relative
low number of patients included in each center, this could not
be accurately explored.
CONCLUSIONS
In conclusion, the in-hospital mortality rate of septic
patients admitted to internal medicine units appeared in line
with recent reports of the literature in ICU setting. Besides the
clinical presentation as severe sepsis or septic shock, other
factors appeared to be helpful in defining the short-term prog-
nosis of septic patients and may be used to define the adequate
management of these patients. However, other larger prospec-
tive studies are warranted to confirm our preliminary findings.
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